Benzothiazole and stilbene derivatives as promising positron emission tomography myelin radiotracers for multiple sclerosis-Reference-Cited by-同舟云学术

Benzothiazole and stilbene derivatives as promising positron emission tomography myelin radiotracers for multiple sclerosis

Published:2016-05-09 Issue:1 Volume:80 Page:166-167
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Bodini Benedetta¹,Veronese Mattia²,Turkheimer Federico²,Stankoff Bruno¹

Affiliation:

1. Institut du Cerveau et de la Moelle Epiniere, Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, and CNRS UMR 7225, and ICM, F-75013; Paris France

2. Department of Neuroimaging, Institute of Psychiatry; King's College London; London United Kingdom

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference6 articles.

1. Dynamic imaging of individual remyelination profiles in multiple sclerosis;Bodini;Ann Neurol

2. Imaging of CNS myelin by positron-emission tomography;Stankoff;Proc Natl Acad Sci U S A,2006

3. Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-(1)(1)C]-2-(4′-methylaminophenyl)-6-hydroxybenzothiazole;Stankoff;Ann Neurol,2011

4. Amyloid PET imaging in multiple sclerosis: an (18)F-florbetaben study;Matías-Guiu;BMC Neurol,2015

5. Cerebrospinal fluid anti-amyloid-β autoantibodies and amyloid PET in cerebral amyloid angiopathy-related inflammation;Carmona-Iragui;J Alzheimers Dis,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myelin in the Central Nervous System: Structure, Function, and Pathology;Physiological Reviews;2019-07-01

2. Comparison of Pittsburgh compound B and florbetapir in cross‐sectional and longitudinal studies;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2019-02-22

3. Ultrahigh field imaging of myelin disease models: Toward specific markers of myelin integrity?;Journal of Comparative Neurology;2019-01-04

4. MRI in multiple sclerosis;Current Opinion in Neurology;2018-06

5. Sphingomyelin as a myelin biomarker in CSF of acquired demyelinating neuropathies;Scientific Reports;2017-08-10